PES is delighted to be supporting AbbVie Ireland on the current expansion of their facility at Ballytivnan, Sligo, Ireland.  The investment in new sterile manufacturing capability will expand AbbVie’s current oncology drug pipeline.

Our team on site is focused primarily on the management of process packages, along with the commissioning and qualification of the new facility.

AbbVie is a US publicly traded biopharmaceutical company founded in 2013, with a workforce of 30,000 employees, and a portfolio of products including the blockbuster drug Humira.